No fees unless we win.
Get a free consultation
The anticoagulant Pradaxa was approved for use in the U.S. and Canada in 2010 based off a large global study called the RE-LY trial (the acronym for “Randomized Evaluation of Long-Term Anticoagulation Therapy). However, the original number of Pradaxa caused deaths in the study has increased.
This is the second time in four years that the authors of the RE-LY study have revised the number of deaths. According to The Hamilton Spectator, “the authors state a review of clinical trial data shows 20 additional deaths were found that should have been linked to adverse events in patients participating in the study.”
The authors also noted that lawyers for plaintiffs discovered seven other possible deaths linked to Pradaxa use. Of the 18,000 patients that took part in the RE-LY study, there were nearly 1,400 deaths.
Pradaxa was approved as an alternative to the drug warfarin. Both of these drugs treat patients at risk of stroke caused by a type of heart arrhythmia called atrial fibrillation.
Decades prior to Pradaxa’s approval, warfarin was the popular anticoagulant of choice. Warfarin requires frequent blood monitoring, but there is an antidote if unexpected bleeding occurs.
Pradaxa is easier to manage, but it has no antidote for bleeding. This makes it very dangerous; once something goes wrong, it may result in severe adverse health risks or even death. Some of the health risks include:
Our attorneys have been working hard to investigate the health risks associated with Pradaxa use. If you have been injured by taking this anticoagulant, contact our firm at (888)841-9623.
Zoll & Kranz, LLC – Defective Medical Drug and Device Lawyers
ZK Law Note: According to The Hamilton Spectator, there is a worldwide clinical trial to test an antidote for Pradaxa to reverse cases of unexpected bleeding.
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
